Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes

Abstract

The arbovirus life cycle involves viral transfer between a vertebrate host and an arthropod vector, and acquisition of virus from an infected mammalian host by a vector is an essential step in this process. Here, we report that flavivirus nonstructural protein-1 (NS1), which is abundantly secreted into the serum of an infected host, plays a critical role in flavivirus acquisition by mosquitoes. The presence of dengue virus (DENV) and Japanese encephalitis virus NS1s in the blood of infected interferon-α and γ receptor-deficient mice (AG6) facilitated virus acquisition by their native mosquito vectors because the protein enabled the virus to overcome the immune barrier of the mosquito midgut. Active immunization of AG6 mice with a modified DENV NS1 reduced DENV acquisition by mosquitoes and protected mice against a lethal DENV challenge, suggesting that immunization with NS1 could reduce the number of virus-carrying mosquitoes as well as the incidence of flaviviral diseases. Our study demonstrates that flaviviruses utilize NS1 proteins produced during their vertebrate phases to enhance their acquisition by vectors, which might be a result of flavivirus evolution to adapt to multiple host environments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: DENV sNS1 facilitates DENV acquisition via membrane blood feeding.
Figure 2: Passive transfer of DENV2 sNS1 antibodies into infected AG6 mice prevents DENV acquisition by mosquitoes.
Figure 3: Passive transfer of antibodies against JEV NS1 in infected AG6 mice prevents JEV acquisition by Culex pipiens pallens.
Figure 4: DENV2 sNS1 suppresses the expression of immune-related genes in the mosquito midgut.
Figure 5: An antibody generated against DENV2 ΔNS1 does not cross-react with human cells and prevents DENV acquisition by mosquitoes.
Figure 6: NS1 vaccination prevents DENV infections in mice and mosquitoes.

Similar content being viewed by others

References

  1. Gould, E. A. & Solomon, T. Pathogenic flaviviruses. Lancet 371, 500–509 (2008).

    Article  Google Scholar 

  2. Rigau-Perez, J. G. et al. Dengue and dengue haemorrhagic fever. Lancet 352, 971–977 (1998).

    Article  Google Scholar 

  3. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013).

    Article  Google Scholar 

  4. Campbell, G. L. et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ. 89, 766–774 (2011).

    Article  Google Scholar 

  5. Muller, D. A. & Young, P. R. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 98, 192–208 (2013).

    Article  Google Scholar 

  6. Akey, D. L. et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343, 881–885 (2014).

    Article  Google Scholar 

  7. Young, P. R., Hilditch, P. A., Bletchly, C. & Halloran, W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38, 1053–1057 (2000).

    Google Scholar 

  8. Alcon, S. et al. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40, 376–381 (2002).

    Article  Google Scholar 

  9. Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141 (2015).

    Article  Google Scholar 

  10. Modhiran, N. et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 304ra142 (2015).

    Article  Google Scholar 

  11. Avirutnan, P. et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207, 793–806 (2010).

    Article  Google Scholar 

  12. Schlesinger, J. J., Brandriss, M. W. & Walsh, E. E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus nonstructural glycoprotein NS1. J. Gen. Virol. 68, 853–857 (1987).

    Article  Google Scholar 

  13. Lin, C. F. et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J. Immunol. 174, 395–403 (2005).

    Article  Google Scholar 

  14. Liu, I. J., Chiu, C. Y., Chen, Y. C. & Wu, H. C. Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J. Biol. Chem. 286, 9726–9736 (2011).

    Article  Google Scholar 

  15. Omokoko, M. D. et al. A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients. Am. J. Trop. Med. Hyg. 91, 146–155 (2014).

    Article  Google Scholar 

  16. Cheng, H. J. et al. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. Mol. Immunol. 47, 398–406 (2009).

    Article  Google Scholar 

  17. Liu, Y. et al. Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention. PLoS Pathogens 10, e1003931 (2014).

    Article  Google Scholar 

  18. Cheng, G., Liu, Y., Wang, P. & Xiao, X. Mosquito defense strategies against viral infection. Trends Parasitol. 32, 177–186 (2016).

    Article  Google Scholar 

  19. Chung, K. M. & Diamond, M. S. Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. J. Med. Virol. 80, 547–556 (2008).

    Article  Google Scholar 

  20. Tan, G. K. et al. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. PLoS Negl. Trop. Dis. 4, e672 (2010).

    Article  Google Scholar 

  21. Orozco, S. et al. Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J. Gen. Virol. 93, 2152–2157 (2012).

    Article  Google Scholar 

  22. Halstead, S. B. Dengue. Lancet 370, 1644–1652 (2007).

    Article  Google Scholar 

  23. Guo, X. X. et al. Vector competence of Aedes albopictus and Aedes aegypti (Diptera: Culicidae) for DEN2-43 and New Guinea C virus strains of dengue 2 virus. Acta Trop. 128, 566–570 (2013).

    Article  Google Scholar 

  24. Sang, S. et al. Predicting unprecedented dengue outbreak using imported cases and climatic factors in Guangzhou, 2014. PLoS Negl. Trop. Dis. 9, e0003808 (2015).

    Article  Google Scholar 

  25. Takamatsu, Y. et al. NS1′ protein expression facilitates production of Japanese encephalitis virus in avian cells and embryonated chicken eggs. J. Gen. Virol. 95, 373–383 (2014).

    Article  Google Scholar 

  26. Xi, Z., Ramirez, J. L. & Dimopoulos, G. The Aedes aegypti toll pathway controls dengue virus infection. PLoS Pathogens 4, e1000098 (2008).

    Article  Google Scholar 

  27. Sánchez-Vargas, I. et al. Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito's RNA interference pathway. PLoS Pathogens 5, e1000299 (2009).

    Article  Google Scholar 

  28. Souza-Neto, J. A., Sim, S. & Dimopoulos, G. An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense. Proc. Natl Acad. Sci. USA 106, 17841–17846 (2009).

    Article  Google Scholar 

  29. Carissimo, G. et al. Antiviral immunity of Anopheles gambiae is highly compartmentalized, with distinct roles for RNA interference and gut microbiota. Proc. Natl Acad. Sci. USA 112, E176–E185 (2015).

    Article  Google Scholar 

  30. Cirimotich, C. M. et al. Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae. Science 332, 855–858 (2011).

    Article  Google Scholar 

  31. Lee, K. A. et al. Bacterial-derived uracil as a modulator of mucosal immunity and gut–microbe homeostasis in Drosophila. Cell 153, 797–811 (2013).

    Article  Google Scholar 

  32. Dostert, C. et al. The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of Drosophila. Nature Immunol. 6, 946–953 (2005).

    Article  Google Scholar 

  33. The malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 8, e1000398 (2011).

    Article  Google Scholar 

  34. Falconar, A. K. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142, 897–916 (1997).

    Article  Google Scholar 

  35. Calvert, A. E., Huang, C. Y., Kinney, R. M. & Roehrig, J. T. Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge. J. Gen. Virol. 87, 339–346 (2006).

    Article  Google Scholar 

  36. Amorim, J. H. et al. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine 30, 837–845 (2012).

    Article  Google Scholar 

  37. Pan, X. et al. Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti. Proc. Natl Acad. Sci. USA 109, E23–E31 (2012).

    Article  Google Scholar 

  38. Cheng, G. et al. A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes. Cell 142, 714–725 (2010).

    Article  Google Scholar 

  39. Londono-Renteria, B. et al. Dengue virus infection of Aedes aegypti requires a putative cysteine rich venom protein. PLoS Pathogens 11, e1005202 (2015).

    Article  Google Scholar 

  40. Miura, K. et al. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malaria J. 6, 107 (2007).

    Article  Google Scholar 

  41. Chowdhury, D. R., Angov, E., Kariuki, T. & Kumar, N. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli. PLoS ONE 4, e6352 (2009).

    Article  Google Scholar 

  42. Bai, F. et al. Antiviral peptides targeting the West Nile virus envelope protein. J. Virol. 81, 2047–2055 (2007).

    Article  Google Scholar 

  43. Falconar, A. K. & Young, P. R. Immunoaffinity purification of the native dimer forms of the flavivirus non-structural protein, NS1. J. Virol. Methods 30, 323–332 (1990).

    Article  Google Scholar 

  44. Cepko, C. Large-scale preparation and concentration of retrovirus stocks. Curr. Protoc. Mol. Biol. 9, 9.12.1–9.12.6 (2001).

    Google Scholar 

  45. Estridge, B. H., Reynolds, A. P. & Walters, N. J. Basic Medical Laboratory Techniques Ch. 2 (Cengage Learning, 2000).

    Google Scholar 

  46. Graham, J. Isolation of human platelets (thrombocytes). Sci. World J. 2, 1607–1609 (2002).

    Article  Google Scholar 

Download references

Acknowledgements

This work was funded by grants from the National Natural Science Foundation of China (81301412, 81422028 and 81571975), National Program on Key Research Project of China (Prevention of livestock and poultry diseases and development of comprehensive farming technology), the National Key Basic Research Program of MOST (2013CB911500), Grand Challenges Explorations of the Bill & Melinda Gates Foundation (OPP1021992) and the National Institutes of Health of the USA (AI103807). The authors thank S. B. Halstead for providing critical suggestions for the manuscript. G.C. is a Newton Advanced Fellow (awarded by the Academy of Medical Sciences and the Newton Fund). G.C. is also a Janssen Investigator at Tsinghua University. The authors acknowledge the core facilities of the Center for Life Sciences and Center of Biomedical Analysis for technical assistance (Tsinghua University).

Author information

Authors and Affiliations

Authors

Contributions

G.C. designed the experiments and wrote the manuscript. Y.L. and J.L. performed the majority of the experiments and analysed data. K.N., S.D. and X.P. helped with RNA isolation and qPCR detection. J.Q. assisted in the statistical analysis. P.W. contributed experimental suggestions and improved the writing of the manuscript. All authors reviewed, critiqued and provided comments on the manuscript.

Corresponding author

Correspondence to Gong Cheng.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary Figures 1-11, Supplementary Tables 1 and 2. (PDF 2428 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Liu, Y., Nie, K. et al. Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes. Nat Microbiol 1, 16087 (2016). https://doi.org/10.1038/nmicrobiol.2016.87

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/nmicrobiol.2016.87

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing